Factors Associated With Hypoventilation in the Myotonic Dystrophy, Progressive Profile Over 5 Years
Steinert
Steinert
Sponsor study identifier
Secondary identifiers
OTHER · ID-RCB number, ANSM
observational
113
1 country
6
Study Start
June 30, 2010
Actual (reported)Primary Completion
June 11, 2023
Actual (reported)Study Completion
June 11, 2023
Actual (reported)The aim of this study is to determine the factors associated with alveolar hypoventilation in terms of cognitive impairment, daytime sleepiness, respiratory function, nocturnal respiratory events This evaluation will clarify the clinical phenotypes of respiratory disease in myotonic steinert dystrophy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 11, 2023
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 30, 2010
Actual (reported)November 19, 2018
Actual (reported)December 4, 2018
Actual (reported)June 11, 2023
Actual (reported)June 11, 2023
Actual (reported)Change of measurement of spirometry
composite predictive factors of alveolar hypoventilation
every year during 5 years
Change respiratory force
composite predictive factors of alveolar hypoventilation to change Inspiratory and expiratory force
every year during 5 years
Change CO2 response (Read test)
composite predictive factors of alveolar hypoventilation
every year during 5 years
Change subjective sleepiness (Epworth)
composite predictive factors of alveolar hypoventilation
every year during 5 years
change Krupp's Fatigue Severity Scale (KFSS)
composite predictive factors of alveolar hypoventilation This is a short questionnaire of 9 questions to which the patient responds on a Likert scale ranging from 1 to 7
every year during 5 years
Diurnal hypercapnia defined by PaCO2\> 45 mmHg
PaCO2 diurnal within the limits of normal (PaCO2 \<45 mmHg)
patient with a myotonic dystrophy of Steinert who consults in pneumology and who will have Respiratory functional exploration
Centre Hospitalier Regional D' Angers
Angers, France
Ap-Hp Hu Paris Site Raymond Poincare
Garches, France
Hôpital Calmette, CHRU
Lille, France
Chu Montpellier
Montpellier, France
Chu de Nantes :Site Hôtel-Dieu- Hme - Nantes 1
Nantes, France
Ap-Hp Hu Pitie Salpetriere
Paris, France
Thierry Perez, MD
University Hospital, Lille
113 participants (actual enrollment reported by the registry).
First Submitted
November 19, 2018
First Posted
December 4, 2018
Study Start
June 30, 2010
Actual (reported)Efficacy and Safety of DHEA for Myotonic Dystrophy
change cognitive impairment by Trail Making Test A & B
composite predictive factors of alveolar hypoventilation Trail Making Test is a neuropsychological test of visual attention and task switching. It consists of two parts in which the subject is instructed to connect a set of 25 dots as quickly as possible while still maintaining accuracy.
every year during 5 years
change Oximetry
composite predictive factors of alveolar hypoventilation
every year during 5 years
Contact the study team to confirm eligibility.
Primary Completion
June 11, 2023
Actual (reported)Study Completion
June 11, 2023
Actual (reported)Last Updated
December 5, 2025
Record last verified: 2025-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: